CN1164413A - Chinese patent drug for treatment of diabetes mellitus - Google Patents
Chinese patent drug for treatment of diabetes mellitus Download PDFInfo
- Publication number
- CN1164413A CN1164413A CN 97104073 CN97104073A CN1164413A CN 1164413 A CN1164413 A CN 1164413A CN 97104073 CN97104073 CN 97104073 CN 97104073 A CN97104073 A CN 97104073A CN 1164413 A CN1164413 A CN 1164413A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese patent
- root
- medicine
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The Chinese patent medicine oral liquor for curing diabetes mellitus is made up by using 16 Chinese medicinal materials of astragalus root, American ginseng, cornus fruit, cuscuta seed, dried pulvis of placenta, schisandra berry, Chinese angelica root, dragon's blood, salvia root, trichosanthes root, dendrobium stem, scrophularia root, ophiopogon tuber, raw Chinese yam, dried/fresh rehmannia and pueraria root according to its prescription formed on the basis of such principles of boosting qi and nourishing yin, supporting right and dispeling evil, cooling blood and quickening blood circulation and clearing heat and drying dampness. Said invented oral liquor possesses therapy of both disease symptom and cause, high therapeutic effect, and has no toxic side-effect.
Description
The invention belongs to a kind of oral Chinese patent medicine for the treatment of diabetes.
Diabetes are the doctor trained in Western medicine name of disease, and the traditional Chinese medical science is called diabetes, and domestic sickness rate is about about 0.7%, and obvious ascendant trend is arranged.Though the medicine of western medical treatment primary disease is a lot of at present, curative effect is not consolidated, and primary disease belongs to a kind of systemic disease, and the traditional Chinese medical science also has many medicines, and is each has something to recommend him, but generally speaking still belong to a kind of disease of refractory.
The present invention aims to provide a kind of malicious pair and does little and can obtain the oral Chinese patent medicine of the treatment diabetes of better curative effect.
The technical scheme that realizes above-mentioned purpose is that raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (b is Unit Weight part):
Radix Astragali 25-35b Radix Panacis Quinquefolii 25-35b Fructus Corni 17-23b Semen Cuscutae 12-18b
Placenta Hominis 17-23b Fructus Schisandrae Chinensis 10-14b Radix Angelicae Sinensis 10-14b Sanguis Draxonis 4-6b
Radix Salviae Miltiorrhizae 10-14b Radix Trichosanthis 25-35b Herba Dendrobii 12-18b Radix Scrophulariae 17-23b
Radix Ophiopogonis 10-14b Rhizoma Dioscoreae 17-23b Radix Rehmanniae 17-23b Radix Puerariae 12-18b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Diabetes are that due to endocrine regulation was lacked of proper care, its clinical manifestation mainly was that blood stasis is scorching because a variety of causes causes immune function of human body to descend.It is considered herein that and answer treating both the principal and secondary aspects of a disease can obtain desirable curative effect that aspect effecting a permanent cure, resets mends " kidney ", " gas " of human body, improve the endocrine ability of self regulation, aspect taking stopgap measures, then, improve symptom at diabetes patient's " dry ", " wetting ", " stasis of blood " clinically.Therefore our with supplementing QI and nourishing YIN, strengthening vital QI to eliminate pathogenic factors, removing heat from blood and promoting blood circulation, heat clearing and damp drying are the principles of formulating prescriptions.The Radix Astragali, Radix Panacis Quinquefolii, Fructus Corni, Semen Cuscutae, Placenta Hominis have the kidney tonifying QI invigorating in the side, improve the organism endocrine regulatory function, Radix Panacis Quinquefolii is wherein mended and not dry, and Fructus Corni can improve immunologic function, Placenta Hominis has endocrine regulation and hormone-like effect, and these a few flavor medicines have blood sugar reducing function more;
Radix Angelicae Sinensis has remarkable increase coronary flow and blood vessel dilating effect in the side, and can effectively suppress the anaerobic condition of tissue, Sanguis Draxonis is the Chinese medicine tradition stasis-breaking drug of invigorating blood circulation, modern age, pharmacological research confirmed to have the blood circulation of improvement and blood sugar reducing function, Radix Salviae Miltiorrhizae is drug for invigorating blood circulation and eliminating stasis commonly used, and three flavors play blood circulation promoting and blood stasis dispelling altogether, improve the blood circulation effect;
Fructus Schisandrae Chinensis, Radix Trichosanthis, Herba Dendrobii, Radix Scrophulariae, Radix Ophiopogonis, Rhizoma Dioscoreae, the Radix Rehmanniae, Radix Puerariae are the medicine of heat clearing and damp drying yin nourishing removing heat from blood in the side, and Radix Trichosanthis wherein, Radix Ophiopogonis, the Radix Rehmanniae, Rhizoma Dioscoreae still have blood sugar reducing function.
Full side ten Six-element medicines cooperate the effect of playing supplementing QI and nourishing YIN, strengthening vital QI to eliminate pathogenic factors, removing heat from blood and promoting blood circulation, heat clearing and damp drying.
Clinical analysis
The criterion of therapeutical effect that reference " technological guidance's principle of new Chinese medicine treatment diabetes clinical research " and nineteen eighty-two whole nation diabetes meeting are drafted, the comprehensive therapeutic effect evaluation is carried out in medication after 60 days.Including 316 cases of statistics in, is the complete type ii diabetes patient of observed and recorded (the type i diabetes people does not list scope of statistics in).
A, 316 routine type ii diabetes people blood sugar lowering curative effect statistical tables (by the blood sugar level statistics)
Curative effect | Produce effects enabledisable subtotal |
Example number % | ????114????174?????28?????316 ????36.1???55.1????8.8????100 |
Total effective 288 people of this group case blood sugar lowering, effective percentage 91.2% is controlled undesirable person 28 people, inefficiency 8.8%.B, 316 routine diabetes patient's clinical symptoms are improved statistical table
Symptom | Before the treatment | After the treatment | ||
Example number % | It is invalid that produce effects takes a turn for the better | |||
Example number % | Example number % | Example number % | ||
The polydipsia polyuria polyphagia scorching itching over the body edema of becoming thin is unable | ?298????94.3 ?270????85.4 ?192????60.7 ?176????55.7 ?264????83.5 ?253????46.2 | ??156????52.3 ??161????59.6 ???73????38 ??152????86.4 ??138????60 ??186????58.9 | ??140????47.1 ??106????39.3 ??107????61 ???24????13.6 ??126????40 ???67????41.1 | ????2????6 ????3????1.1 ????4????1 ????0????0 ????0????0 ????0????0 |
More than statistics as can be known, clinical symptoms all is significantly improved after the medication, and is particularly unable etc. all effectively to scorching itching over the body, edema.
Model case
1, Wang Li spends the accounting of 56 years old Xinjiang of woman Urumqi City building constructor
On May 27th, 94 examined, and the patient claimed to suffer from diabetes 5 years, once obeyed multiple blood sugar lowering Western medicine, the blood sugar urinary sugar horizontal instability, and every day, brothers' heart burnt, and it is unable to become thin, and looks into patient's blood glucose 14.6mmol/L glucose in urine (+++), rolling pulse, yellow fur.Advise this beneficial sugared capsule for eliminating of clothes, every day three times, each 9, symptom is obviously improved after two weeks of medication, and brothers' heart burns and stops substantially, and thirsty and hunger sensation alleviates, the efficacy consolidation in January of taking medicine again, the Western medicine of all stopping using.Check on July 6, fasting glucose has been reduced to normally, and glucose in urine (-) is evident in efficacy.
2, Li Lianying, man, 64 years old, Chengdu, the Sichuan retired staff of bank.Examine March 27 nineteen ninety-five, claim to suffer from diabetes 12 years, once used multiple in, western medicine, the state of an illness is repeatedly recently, glucose in urine is frequent +++extremely ++ ++, polyuria, polydipsia, malaise, skin pruritus is advised the sugared capsule for eliminating of this medicine of clothes benefit, every day three times, each 9, the further consultation in month of taking medicine, thirsty and pruritus symptom alleviates, and blood glucose is reduced to 7.6mmol/L, glucose in urine (+), take medicine January, all diseases disappear entirely again, and blood glucose, glucose in urine are reduced to normal level.
This Chinese patent medicine treating both the principal and secondary aspects of a disease, clinical efficacy is remarkable, and the effective percentage height has no side effect.
The embodiment explanation
Embodiment 1
Every dose of raw material of Chinese medicine that is adopted of this routine Chinese patent medicine and weight proportion are:
Radix Astragali 30g Radix Panacis Quinquefolii 30g Fructus Corni 20g Semen Cuscutae 15g
Placenta Hominis 20g Fructus Schisandrae Chinensis 12g Radix Angelicae Sinensis 12g Sanguis Draxonis 5g
Radix Salviae Miltiorrhizae 12g Radix Trichosanthis 30g Herba Dendrobii 15g Radix Scrophulariae 20g
Radix Ophiopogonis 12g Rhizoma Dioscoreae 20g Radix Rehmanniae 20g Radix Puerariae 15g
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation;
Manufacture method: elder generation chooses decontamination with above-mentioned 16 flavor medicines, is ground into fine powder, crosses 100 mesh sieves, gets final product in the 0.5g capsule of again medicated powder being packed into, with cobalt 60 radiation sterilizations, with favorable moth-proof or fungus growth, can make the interior preservation of capsule 2-3 good.
Instructions of taking is obeyed three every day, and according to year order and state of an illness clothes 6-9 grain (3-4.5g), medication 30 days was a course of treatment at every turn, and the period in a medicine patient must control high-carbohydrate food, cooperates moderate exercise, formerly takes blood sugar lowering Western medicine person and withdraws gradually.
Embodiment 2
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (b is Unit Weight part):
Radix Astragali 35b Radix Panacis Quinquefolii 35b Fructus Corni 17b Semen Cuscutae 12b
Placenta Hominis 23b Fructus Schisandrae Chinensis 14b Radix Angelicae Sinensis 10b Sanguis Draxonis 4b
Radix Salviae Miltiorrhizae 14b Radix Trichosanthis 35b Herba Dendrobii 12b Radix Scrophulariae 17b
Radix Ophiopogonis 14b Rhizoma Dioscoreae 23b Radix Rehmanniae 17b Radix Puerariae 12b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Embodiment 3
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (b is Unit Weight part):
Radix Astragali 25b Radix Panacis Quinquefolii 25b Fructus Corni 23b Semen Cuscutae 18b
Placenta Hominis 17b Fructus Schisandrae Chinensis 10b Radix Angelicae Sinensis 14b Sanguis Draxonis 6b
Radix Salviae Miltiorrhizae 10b Radix Trichosanthis 25b Herba Dendrobii 18b Radix Scrophulariae 23b
Radix Ophiopogonis 10b Rhizoma Dioscoreae 17b Radix Rehmanniae 23b Radix Puerariae 18b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of diabetes is characterized in that, raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (b is Unit Weight part):
Radix Astragali 25-35b Radix Panacis Quinquefolii 25-35b Fructus Corni 17-23b Semen Cuscutae 12-18b
Placenta Hominis 17-23b Fructus Schisandrae Chinensis 10-14b Radix Angelicae Sinensis 10-14b Sanguis Draxonis 4-6b
Radix Salviae Miltiorrhizae 10-14b Radix Trichosanthis 25-35b Herba Dendrobii 12-18b Radix Scrophulariae 17-23b
Radix Ophiopogonis 10-14b Rhizoma Dioscoreae 17-23b Radix Rehmanniae 17-23b Radix Puerariae 12-18b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, Chinese patent medicine according to claim 1 is characterized in that, raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (b is Unit Weight part):
Radix Astragali 30b Radix Panacis Quinquefolii 30b Fructus Corni 20b Semen Cuscutae 15b
Placenta Hominis 20b Fructus Schisandrae Chinensis 12b Radix Angelicae Sinensis 12b Sanguis Draxonis 5b
Radix Salviae Miltiorrhizae 12b Radix Trichosanthis 30b Herba Dendrobii 15b Radix Scrophulariae 20b
Radix Ophiopogonis 12b Rhizoma Dioscoreae 20b Radix Rehmanniae 20b Radix Puerariae 15b
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97104073A CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97104073A CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1164413A true CN1164413A (en) | 1997-11-12 |
CN1055009C CN1055009C (en) | 2000-08-02 |
Family
ID=5167110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97104073A Expired - Fee Related CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1055009C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006117566A3 (en) * | 2005-05-03 | 2007-06-14 | Ultra Biotech Ltd | Botanical anticancer formulations |
CN100335080C (en) * | 2003-12-12 | 2007-09-05 | 陈永军 | Medication for treating diabetes |
CN100443103C (en) * | 2006-11-10 | 2008-12-17 | 广西中医学院 | Pharmaceutical composition for treating diabetes complication and preparation process thereof |
CN104491529A (en) * | 2014-12-16 | 2015-04-08 | 济南方宇文化传媒有限公司 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743599A (en) * | 2012-07-05 | 2012-10-24 | 许瑞琴 | Traditional Chinese medicine for treating diabetes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1124154A (en) * | 1995-03-30 | 1996-06-12 | 随嫣玲 | Traditional Chinese medicine for effectively curing diabetes and preparing method |
-
1997
- 1997-04-25 CN CN97104073A patent/CN1055009C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100335080C (en) * | 2003-12-12 | 2007-09-05 | 陈永军 | Medication for treating diabetes |
WO2006117566A3 (en) * | 2005-05-03 | 2007-06-14 | Ultra Biotech Ltd | Botanical anticancer formulations |
CN100443103C (en) * | 2006-11-10 | 2008-12-17 | 广西中医学院 | Pharmaceutical composition for treating diabetes complication and preparation process thereof |
CN104491529A (en) * | 2014-12-16 | 2015-04-08 | 济南方宇文化传媒有限公司 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1055009C (en) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101745078A (en) | Chinese medicinal composition for treating cardiac failure and preparation method thereof | |
CN102552761A (en) | Chinese medicinal pills for treating psoriasis | |
CN1055009C (en) | Chinese patent drug for treatment of diabetes mellitus | |
CN102000238B (en) | Martianus dermestoides capsule and preparation method | |
CN106214740A (en) | A kind of Chinese medicine composition and its production and use | |
CN111481638A (en) | Traditional Chinese medicine enema preparation for treating ulcerative colitis and preparation method thereof | |
CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
CN101618172B (en) | Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites | |
CN104873911B (en) | A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment | |
CN1055226C (en) | Medicine for curing trichomadesis and its preparation method | |
CN1857515B (en) | Skin care Chinese medicine film preparation and its preparing process | |
CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
CN114404490B (en) | Traditional Chinese medicine for treating leucopenia after tumor radiotherapy and chemotherapy and preparation method | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
CN1233409C (en) | Combination of Chinese traditional medicine for health preservation and preparation method | |
CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
CN108186967A (en) | One kind keeps fit and healthy health-preserving medicinal liquor and preparation method thereof | |
CN1248470A (en) | Chinese patent drug-Yibao for treating diabetes | |
CN105311419A (en) | Traditional Chinese medicine composition for treating oral inflammations and preparation method thereof | |
CN1111031C (en) | Medicine for treating leukoderma | |
CN113116991A (en) | Chinese medicinal preparation for treating nephrosis and nephrotic syndrome and preparation method thereof | |
CN1181864C (en) | Pain eliminating liquor No.1 | |
CN104027789A (en) | Traditional Chinese medicine composition for treating cold retardation type jaundice of newborn babies and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |